Daily Current Affairs — 3 February 2026
5 articles • UPSC Prelims & Mains
Budget 2026: Govt Backs Orange Economy
In News The Union Budget 2026–27, presented by the Finance Minister, placed India’s creative industries at the centre of a services-led growth strategy, marking a clear policy push towards the Orange Economy. What is the Orange Economy? The Orange Economy, also known as the Creative Economy is a knowledge-based sector where the value of products and services is derived from ideas, cultural capital, and intellectual property (IP) rather than physical goods.
2026 Delhi Declaration
Context India hosted 22 members of the League of Arab States (AL) for the second India-Arab Foreign Ministers Meeting, 10 years after the first iteration in Bahrain. About This meeting occurred amid escalating tensions between Iran and the US, a growing rift between Saudi Arabia and UAE, and the US led Board of Peace attempting a new approach to resolving the Israel-Palestine question. In a joint statement called the Delhi Declaration, India and the Arab League clarified their positions on a num
DAY NRLM: Next Phase of Rural Women’s Empowerment
Context The Deendayal Antyodaya Yojana–National Rural Livelihoods Mission (DAY NRLM) is transitioning into a new phase, often referred to as NRLM 2.0, and prepares for the next five-year cycle (2026–27 to 2030–31). About DAY NRLM It is a flagship poverty alleviation and women empowerment programme, launched in 2011 by the Union Ministry of Rural Development. It aims to reduce rural poverty by enabling poor households, especially women to access sustainable livelihoods through strong, community-b
India–US Signed Trade Agreement
In News India and the United States have announced a new trade deal, lowering tariffs and setting ambitious targets for bilateral trade. About the India–US Trade Deal Tariff reduction: US reciprocal tariffs on Indian goods reduced from 25% to 18%, effective immediately. Additional 25% duty withdrawn, which had earlier been imposed.
Transforming India into a Global Biopharma Hub
Context Union Budget 2026–27 proposed the Biopharma SHAKTI with an outlay of Rs. 10,000 crores over five years, aimed at strengthening India’s ecosystem for production of biologics and biosimilars. Biopharma Biopharma, or biopharmaceuticals, refers to the part of the pharmaceutical industry that focuses on developing and manufacturing medicines using living biological systems, rather than relying solely on chemical synthesis.